OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
Active, not recruiting · NCT03716102 · Registry updated 2020-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study | acute coronary syndrome, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2020-06-26 | NCT03716102 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Svelte Medical Systems, Inc. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northern Michigan Hospital d.b.a McLaren Northern Michigan | Petoskey | United States | 1 |
| Scottsdale Healthcare | Scottsdale | United States | 1 |